Pharmacological modification of the vascular response to systemically administered thrombolytic enzymes (CA-7).
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001780:Blood Coagulation Tests; D001794:Blood Pressure / Q000187:drug effects*; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D005263:Femoral Artery / Q000187:drug effects; D006400:Hematocrit; D007705:Kinins / Q000097:blood; D008297:Male; D008680:Metaraminol / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010447:Peptide Hydrolases / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D011480:Protease Inhibitors
D007705:Kinins; D011480:Protease Inhibitors; D001285:Atropine; D008680:Metaraminol; D011433:Propranolol; D010447:Peptide Hydrolases; D009638:Norepinephrine; D004837:Epinephrine